Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Novel Noninvasive Nuclear Medicine Imaging Techniques for Cardiac Inflammation.

Kircher M, Lapa C.

Curr Cardiovasc Imaging Rep. 2017;10(2):6. doi: 10.1007/s12410-017-9400-x. Epub 2017 Feb 10. Review.

2.

Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study.

Singh P, Emami H, Subramanian S, Maurovich-Horvat P, Marincheva-Savcheva G, Medina HM, Abdelbaky A, Alon A, Shankar SS, Rudd JH, Fayad ZA, Hoffmann U, Tawakol A.

Circ Cardiovasc Imaging. 2016 Dec;9(12). pii: e004195.

3.
4.

Noninvasive diagnosis of vulnerable coronary plaque.

Pozo E, Agudo-Quilez P, Rojas-González A, Alvarado T, Olivera MJ, Jiménez-Borreguero LJ, Alfonso F.

World J Cardiol. 2016 Sep 26;8(9):520-533. Review.

5.

Clinical Utility and Future Applications of PET/CT and PET/CMR in Cardiology.

Pan JA, Salerno M.

Diagnostics (Basel). 2016 Sep 2;6(3). pii: E32. doi: 10.3390/diagnostics6030032. Review.

6.

Targeting Amino Acid Metabolism for Molecular Imaging of Inflammation Early After Myocardial Infarction.

Thackeray JT, Bankstahl JP, Wang Y, Wollert KC, Bengel FM.

Theranostics. 2016 Jul 15;6(11):1768-79. doi: 10.7150/thno.15929. eCollection 2016.

7.

Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography.

Scherer DJ, Psaltis PJ.

Cardiovasc Diagn Ther. 2016 Aug;6(4):354-67. doi: 10.21037/cdt.2015.12.02. Review.

8.

Noninvasive imaging modalities to visualize atherosclerotic plaques.

Shishikura D.

Cardiovasc Diagn Ther. 2016 Aug;6(4):340-53. doi: 10.21037/cdt.2015.11.07. Review.

9.

Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis.

Dweck MR, Aikawa E, Newby DE, Tarkin JM, Rudd JH, Narula J, Fayad ZA.

Circ Res. 2016 Jul 8;119(2):330-40. doi: 10.1161/CIRCRESAHA.116.307971. Review.

10.

Positron emission tomography imaging of coronary atherosclerosis.

Moss AJ, Adamson PD, Newby DE, Dweck MR.

Future Cardiol. 2016 Jul;12(4):483-96. doi: 10.2217/fca-2016-0017.

11.

Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.

Rischpler C, Dirschinger RJ, Nekolla SG, Kossmann H, Nicolosi S, Hanus F, van Marwick S, Kunze KP, Meinicke A, Götze K, Kastrati A, Langwieser N, Ibrahim T, Nahrendorf M, Schwaiger M, Laugwitz KL.

Circ Cardiovasc Imaging. 2016 Apr;9(4):e004316. doi: 10.1161/CIRCIMAGING.115.004316.

12.

Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk.

Fiz F, Morbelli S, Bauckneht M, Piccardo A, Ferrarazzo G, Nieri A, Artom N, Cabria M, Marini C, Canepa M, Sambuceti G.

World J Radiol. 2016 Jan 28;8(1):82-9. doi: 10.4329/wjr.v8.i1.82.

14.

F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques.

Kang WJ.

Korean J Radiol. 2015 Nov-Dec;16(6):1257-61. doi: 10.3348/kjr.2015.16.6.1257. Epub 2015 Oct 26. Review.

15.

Increased arterial inflammation in individuals with stage 3 chronic kidney disease.

Takx RA, MacNabb MH, Emami H, Abdelbaky A, Singh P, Lavender ZR, di Carli M, Taqueti V, Foster C, Mann J, Comley RA, Weber CI, Tawakol A.

Eur J Nucl Med Mol Imaging. 2015 Oct 14. [Epub ahead of print]

16.

Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction.

Joshi NV, Toor I, Shah AS, Carruthers K, Vesey AT, Alam SR, Sills A, Hoo TY, Melville AJ, Langlands SP, Jenkins WS, Uren NG, Mills NL, Fletcher AM, van Beek EJ, Rudd JH, Fox KA, Dweck MR, Newby DE.

J Am Heart Assoc. 2015 Aug 27;4(9):e001956. doi: 10.1161/JAHA.115.001956.

17.

The role of PET quantification in cardiovascular imaging.

Slomka P, Berman DS, Alexanderson E, Germano G.

Clin Transl Imaging. 2014 Aug 1;2(4):343-358.

18.

The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis.

Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, Yamada A, Oyama-Manabe N, Hirata K, Nishimura M, Tamaki N.

J Nucl Cardiol. 2016 Apr;23(2):244-52. doi: 10.1007/s12350-015-0226-0. Epub 2015 Aug 5.

19.

[18F]FDG Accumulation in Early Coronary Atherosclerotic Lesions in Pigs.

Tarkia M, Saraste A, Stark C, Vähäsilta T, Savunen T, Strandberg M, Saunavaara V, Tolvanen T, Teuho J, Teräs M, Metsälä O, Rinne P, Heinonen I, Savisto N, Pietilä M, Saukko P, Roivainen A, Knuuti J.

PLoS One. 2015 Jun 29;10(6):e0131332. doi: 10.1371/journal.pone.0131332. eCollection 2015.

20.

Inflammation, Atherosclerosis, and Coronary Artery Disease: PET/CT for the Evaluation of Atherosclerosis and Inflammation.

Alie N, Eldib M, Fayad ZA, Mani V.

Clin Med Insights Cardiol. 2015 Jan 7;8(Suppl 3):13-21. doi: 10.4137/CMC.S17063. eCollection 2014. Review.

Supplemental Content

Support Center